Profile data is unavailable for this security.
About the company
JSP Pharmaceutical Manufacturing (Thailand) Public Co., Ltd. is a Thailand-based company, which is engaged in the manufacturing and selling of pharmaceutical, dietary supplementary, traditional medicine and herbal products. The Company's businesses comprise providing services in production and product distribution under the client's brand (OEM); manufacturing and distributing under the Company's brand (Own Brand); manufacturing and distributing hemodialysis solution; providing services in relation to product research and development, laboratory testing, consulting, training and seminar, and other products. Its brands consist of COX, JSP, Suphap Osot, and EVITON. Its supplement products include 4 Mix Oil, Wolffia Cap, Acerola Cherry, Coconut Oil, and Fish Oil. Its herbal products include Curcuma Longa Capsule Formula 5 (Household Remedy License), and Compound Senna Laxative Capsule (Household Remedy License). Its JSP supplement products include pure collagen peptide and Choco drink.
- Revenue in THB (TTM)993.15m
- Net income in THB10.04m
- Incorporated2018
- Employees451.00
- LocationJSP Pharmaceutical Manufacturing (Thailand) PCL255257 Soi. Sathupradit 58,, Bangpongpang,BANGKOK 10120ThailandTHA
- Phone+66 22841218
- Fax+66 22940705
- Websitehttps://www.jsppharma.com/th/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nutrition Profess PCL | 1.08bn | 66.15m | 441.60m | -- | 6.68 | 0.9022 | 4.00 | 0.4081 | 0.5512 | 0.5512 | 9.02 | 4.08 | -- | -- | -- | -- | -- | -- | -- | -- | 85.40 | -- | 6.11 | -- | 3.71 | 14.40 | 0.1617 | -- | -1.84 | -- | -15.21 | -- | -- | -- |
| JSP Pharmactcl Mnfctrng (Thailand) PCL | 993.15m | 10.04m | 920.68m | 451.00 | 91.68 | 1.03 | 24.85 | 0.927 | 0.0212 | 0.0212 | 2.09 | 1.88 | 0.7122 | 4.89 | 8.00 | 2,202,116.00 | -2.30 | 0.7228 | -2.89 | 0.873 | 40.68 | 31.82 | -3.24 | 1.39 | 1.14 | 6.35 | 0.2271 | -- | 43.24 | 17.98 | 363.18 | -28.11 | 22.27 | -- |
| Jack Chia Industries Thailand PCL | 872.89m | 123.68m | 1.14bn | 307.00 | 9.20 | 0.8001 | 8.16 | 1.30 | 9.16 | 9.16 | 64.66 | 105.30 | 0.5505 | 1.83 | 3.95 | 2,843,285.00 | 7.80 | 5.54 | 8.28 | 6.01 | 45.35 | 42.40 | 14.17 | 10.51 | 8.03 | 53.88 | 0.00 | 64.24 | -6.82 | -1.39 | 3.72 | 1.70 | -3.13 | 1.39 |
| Specialty Natural Products PCL | 522.45m | 102.86m | 1.88bn | 285.00 | 18.27 | 2.18 | 14.72 | 3.60 | 0.2540 | 0.2540 | 1.29 | 2.13 | 0.6293 | 2.50 | 4.23 | 1,833,145.00 | 12.17 | 12.42 | 15.35 | 15.64 | 40.62 | 38.86 | 19.34 | 17.55 | 7.62 | 261.91 | 0.0036 | -- | 28.20 | 31.58 | 120.19 | 49.42 | -- | -- |
| Bangkok Lab and Cosmetic PCL | 1.68bn | 188.48m | 2.41bn | 1.11k | 12.80 | 1.43 | 9.59 | 1.44 | 0.3141 | 0.3141 | 2.80 | 2.81 | 0.732 | 2.74 | 4.66 | 1,517,711.00 | 8.36 | 7.24 | 10.41 | 12.57 | 30.39 | 28.80 | 11.42 | 8.08 | 1.44 | 31.98 | 0.1135 | -- | 10.73 | 5.31 | 17.85 | 142.44 | 16.91 | -- |
| Inter Pharma PCL | 2.15bn | 112.01m | 2.60bn | 162.00 | 23.24 | 1.28 | 10.85 | 1.21 | 0.185 | 0.185 | 3.56 | 3.36 | 0.6962 | 3.64 | 6.89 | 13,293,500.00 | 4.00 | 3.98 | 5.34 | 5.19 | 40.52 | 40.40 | 5.75 | 6.01 | 1.23 | 7.92 | 0.1549 | 23.26 | 6.52 | 38.23 | -26.60 | -3.03 | 160.41 | -- |
| T Man Pharmaceutical PCL | 2.35bn | 449.38m | 4.24bn | 960.00 | 9.44 | 2.19 | 7.45 | 1.80 | 1.12 | 1.12 | 5.88 | 4.84 | 0.754 | 2.03 | 3.64 | 2,452,049.00 | 14.40 | -- | 33.57 | -- | 47.67 | -- | 19.09 | -- | 0.9128 | 17.38 | 0.3316 | -- | 12.19 | -- | 4.55 | -- | -- | -- |
